Market Leadership Affymetrix is part of Thermo Fisher Scientific, a global leader in life sciences with a broad portfolio of innovative technologies and extensive customer base across pharmaceutical, diagnostic, and research sectors, presenting numerous upselling and cross-selling opportunities.

Global Footprint With operations and sales across Europe, Asia, and Latin America, there is a significant opportunity to tailor regional marketing strategies and expand market penetration in emerging markets for microarray and gene analysis products.

Research Integration Affymetrix's established reputation with over 2,300 shipped systems and more than 94,500 peer-reviewed publications underscores a strong foundation for promoting advanced sequencing and analytical tools to existing research and academic institutions.

Collaborative Potential Partnering with pharmaceutical, biotech, and diagnostic companies offers direct avenues to supply high-throughput analysis systems, reagents, and support services, especially given the company’s emphasis on translating research into clinical applications.

Innovation and Growth The company’s focus on multiplex and simultaneous biological system analysis suggests ongoing demand for innovative, cutting-edge genotyping and molecular diagnostics solutions, presenting opportunities to introduce new product lines and advancements.